252738 Implementing an SBIRT curriculum for medical residents: Training the next generation of care providers

Tuesday, November 1, 2011: 9:24 AM

Denise Scott, PhD , Department of Pediatrics and Human Genetics, Howard University Hospital, Washington, DC
Abstract: Screening, Brief Intervention, and Referral to Treatment (SBIRT) is an evidence-based cost-effective approach to identifying individuals at risk for/with substance use disorders and intervening early to reduce likelihood of progression to more serious conditions. Embedding SBIRT into mainstream medical care delivery is a high priority for the National Drug Control Strategy. This presentation will provide an overview of a SAMHSA-funded program underway at Howard University Medical School in Washington, DC designed to develop and implement an SBIRT curriculum for medical residents, our next generation of care providers.

Learning Areas:
Public health or related education
Public health or related laws, regulations, standards, or guidelines
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy
Public health or related research
Systems thinking models (conceptual and theoretical models), applications related to public health

Learning Objectives:
Describe the consequences of drug abuse and dependence in America Explain the key principles of the Presidentís National Drug Control Strategy and its increased emphasis on a public health approach Discuss how evidence-based approaches are developed and implemented through research, community action, and clinical preventive services Assess the challenges of moving to a public health approach to reducing the consequences of drug use

Keywords: Alcohol, Other Drugs

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Assistant Professor, expertise in SBIRT
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.